Latest Biovica International News & Updates

See the latest news and media coverage for Biovica. We track all announcements, press releases, and industry mentions in real time, all in one place.

Biovica International (Biovica)

Developer of blood tests for cancer monitoring

biovica.com

Headquarters: Uppsala, Sweden
Founded year: 2009
Company type: Public company
Number of employees: 32–50
Industry: Biotechnology & Medical Research

Last updated October 23

Latest news about Biovica International (Biovica)

In short: Biovica completed a SEK 29.2 million rights issue and presented new FLIPPER trial data.

Company announcements

October 23 Biovica

Biovica fully subscribes rights issue raising SEK 29.2 million

Proceeds increase share capital by SEK 6.5 million and shares by 97.3 million, causing significant dilution for non-participating shareholders.

October 6 Biovica

Biovica publishes share issue memorandum for its rights issue

The company released a memorandum regarding its rights offering to existing shareholders and the public in Sweden.

September 30 Biovica

Biovica approves rights and directed share issues at general meeting

Shareholders approved a SEK 31.3 million capital increase via rights issue at SEK 0.30 per share with HDF Cancer Monitoring BV subscribing in directed placement.

September 9 Biovica

Biovica publishes first quarter financial report

The Q1 2026 report highlights over 3,600 patients in studies, 22 publications, and 26 pharma projects while maintaining FDA clearance.

Media coverage

September 8 Yahoo Finance

Biovica Resolves on a Fully Guaranteed Rights Issue of SEK 29.2 Million

UPPSALA, SE / ACCESS Newswire / September 9, 2026 / (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - INSIDE INFORMATION: The board of directors of AB (publ) ("Biovica" or the "Company...

September 8 Finanznachrichten

Biovica International: Q1 Report - Focused Execution Driving Growth

Biovica delivered 56% sales growth in the first quarter, driven by strong Pharma Services momentum, while taking decisive actions to streamline operations, strengthen leadership, and...

June 17 Dagens industri

Biovica's revenue increased – loss decreased

The cancer diagnostics company Biovica reports an operating result of -18.0 million kronor (-20.3) for the fourth quarter of the broken fiscal year 2025/2026.

March 17 BioSpace

Biovica International AB - Q3 Interim Report Nov 2025-Jan2026 - BioSpace

This information is information that Biovica International is obliged to make public pursuant to the EU Market Abuse Regulation.

Never miss news about Biovica

Track Biovica and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Biovica competitors & trending companies

Browse news for competitors to Biovica and other trending companies.